Providing market intelligence for more than 35 years

In The News

Roku IPO a Success, Despite Gaining Little Revenue From YouTube or Netflix

Amazon, for example, is able to sell its own TV streaming products as well as market and promote those products more prominently on its official website. But user trends favor the company’s services. About 80 percent of millennials say they watch or have access to streaming services, so that’s good news for the company.

“Over the past two-and-a-half years, Roku has expanded their product lines, evolved their platform business with smart-TV makers, and continued to build out its advertising business,” Brett Sappington, director of research at consulting firm Parks Associates, told the LA Times. “A platform-based approach and their advertising business will be keys to their future revenues and success.”

From the article "Roku IPO a Success, Despite Gaining Little Revenue From YouTube or Netflix" by Stephen Jordan.

Previously In The News

With 1 Gbps speeds, Verizon’s 5G fixed wireless service will leapfrog the competition

And speeds appear to matter. Parks Associates reported way back in 2015 that fully one quarter of Americans who switched to a new ISP "did so in order to obtain a faster service at a comparable price....

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...